BioWorld - Friday, March 13, 2026

BioWorld Science

March 22, 2022

View Archived Issues

Researchers discover genetic targets linking endometriosis, ovarian cancer subtypes

Read More

PKMYT1 inhibitor RP-6306 for the treatment of aberrant DNA damage repair-driven cancers

Read More

Chongqing Medical University compounds inhibit GST isozyme Mu, sensitize tumors to cisplatin in vivo

Read More

The role of DNA-PKcs and Fis1 in acute kidney injury pathogenesis

Read More

Hangzhou Bangshun Pharmaceutical discloses ROCK2 inhibitors

Read More

Targeting HIF-1alpha/CXCR4 axis as therapeutic strategy in ESCC

Read More

ASK1 inhibition for the treatment of neuroinflammation, stroke and ALS

Read More

Targeting ART1 improves tumor control in NSCLC

Read More

In vivo data show Evusheld retains neutralizing activity against Omicron SARS-CoV-2 BA.2 subvariant

Read More

RNAGene and PharmAbcine collaborate to develop next-generation mRNA-based antibody therapeutics

Read More

IRLAB to advance IRL-757 for apathy in neurodegenerative disorders

Read More

Chimeron to use NIAID preclinical services program for COVID-19 vaccine candidate

Read More

iTolerance raises financing to advance preclinical programs based on iTOL-100 platform technology

Read More

Philochem and Bracco Imaging collaborate on small molecule for imaging applications

Read More

AU-007 shows promising anticancer activity in murine models

Read More